Evaluation of the efficacy of modified vaccinia Ankara (MVA)/IMVAMUNE against aerosolized rabbitpox virus in a rabbit model.

Evaluation of the efficacy of modified vaccinia Ankara (MVA)/IMVAMUNE against aerosolized rabbitpox virus in a rabbit model.

Item
http://www.wikidata.org/entity/Q37332861
The effects of post-exposure smallpox vaccination on clinical disease presentation: addressing the data gaps between historical epidemiology and modern surrogate model dataImmune requirements of post-exposure immunization with modified vaccinia Ankara of lethally infected miceExperimental infection of cynomolgus macaques (Macaca fascicularis) with aerosolized monkeypox virus.Use of the Aerosol Rabbitpox Virus Model for Evaluation of Anti-Poxvirus Agents.Efficacy of CMX001 as a prophylactic and presymptomatic antiviral agent in New Zealand white rabbits infected with rabbitpox virus, a model for orthopoxvirus infections of humansEfficacy of CMX001 as a post exposure antiviral in New Zealand White rabbits infected with rabbitpox virus, a model for orthopoxvirus infections of humansEstablishment of the black-tailed prairie dog (Cynomys ludovicianus) as a novel animal model for comparing smallpox vaccines administered preexposure in both high- and low-dose monkeypox virus challenges.A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects.Evaluation of inhaled cidofovir as postexposure prophylactic in an aerosol rabbitpox model.Assessment of the protective effect of Imvamune and Acam2000 vaccines against aerosolized monkeypox virus in cynomolgus macaques.Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox - an animal model of smallpoxModified Vaccinia Ankara Virus Vaccination Provides Long-Term Protection against Nasal Rabbitpox Virus ChallengeRepeated high-dose (5 × 10(8) TCID50) toxicity study of a third generation smallpox vaccine (IMVAMUNE) in New Zealand white rabbitsAnimal models of orthopoxvirus infection.Third-generation smallpox vaccines: challenges in the absence of clinical smallpox.The strategic use of novel smallpox vaccines in the post-eradication world.The NYCBH vaccinia virus deleted for the innate immune evasion gene, E3L, protects rabbits against lethal challenge by rabbitpox virus.
P2860

Evaluation of the efficacy of modified vaccinia Ankara (MVA)/IMVAMUNE against aerosolized rabbitpox virus in a rabbit model.

Item
http://www.wikidata.org/entity/Q37332861
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evaluation of the efficacy of ...... itpox virus in a rabbit model.
@en
Evaluation of the efficacy of modified vaccinia Ankara
@nl
type
label
Evaluation of the efficacy of ...... itpox virus in a rabbit model.
@en
Evaluation of the efficacy of modified vaccinia Ankara
@nl
prefLabel
Evaluation of the efficacy of ...... itpox virus in a rabbit model.
@en
Evaluation of the efficacy of modified vaccinia Ankara
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Evaluation of the efficacy of ...... bitpox virus in a rabbit model
@en
P2093
P2860
P304
P31
P356
10.1016/J.VACCINE.2009.06.105
P407
P433
P478
P50
P577
P5875
P698
P932